Literature DB >> 12801435

Current management of postherpetic neuralgia.

Louis M Panlilio1, Paul J Christo, Srinivasa N Raja.   

Abstract

BACKGROUND: The herpes zoster rash occurs when a dormant varicella zoster virus reactivates in dorsal root and cranial nerve ganglia. Pain that persists in the region where this rash occurred after the cutaneous lesions have healed is termed postherpetic neuralgia (PHN). A wide variety of therapies has been used with varying degrees of success to prevent the occurrence of PHN and to reduce pain with established PHN. REVIEW
SUMMARY: In this review, we discuss the clinical presentation of PHN, current strategies for the prevention and management of this disease, and observations that have increased our understanding of the neural mechanisms involved in PHN.
CONCLUSIONS: Several classes of drugs are effective in attenuating the pain and hyperalgesia caused by PHN, but no single drug leads to the complete relief of symptoms. Additional research is needed to improve treatment strategies and define the role of invasive pain management techniques in cases where PHN is associated with intractable pain.

Entities:  

Year:  2002        PMID: 12801435     DOI: 10.1097/00127893-200211000-00002

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  4 in total

Review 1.  Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management.

Authors:  Paul J Christo; Greg Hobelmann; David N Maine
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 2.  Neuropathic Corneal Pain: Approaches for Management.

Authors:  Gabriela Dieckmann; Sunali Goyal; Pedram Hamrah
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

Review 3.  Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment.

Authors:  Young Hoon Jeon
Journal:  Korean J Pain       Date:  2015-07-01

4.  Acupuncture for postherpetic neuralgia: a systematic review protocol.

Authors:  Wang Li; Weina Peng; Jing Zhou; Zhishun Liu
Journal:  BMJ Open       Date:  2014-11-12       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.